465 related articles for article (PubMed ID: 29244965)
1. Management of chronic diabetic foot ulcers using platelet-rich plasma.
Babaei V; Afradi H; Gohardani HZ; Nasseri F; Azarafza M; Teimourian S
J Wound Care; 2017 Dec; 26(12):784-787. PubMed ID: 29244965
[TBL] [Abstract][Full Text] [Related]
2. Autologous platelet-rich plasma for treating chronic wounds.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Expósito JA; Bolíbar I; Rodríguez L; Garcia J
Cochrane Database Syst Rev; 2012 Oct; 10():CD006899. PubMed ID: 23076929
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study.
Singh SP; Kumar V; Pandey A; Pandey P; Gupta V; Verma R
J Wound Care; 2018 Sep; 27(9):550-556. PubMed ID: 30204574
[TBL] [Abstract][Full Text] [Related]
4. Autologous platelet-rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers.
Orban YA; Soliman MA; Hegab YH; Alkilany MM
Wounds; 2022 Feb; 33(2):36-42. PubMed ID: 35108667
[TBL] [Abstract][Full Text] [Related]
5. The Use of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Scoping Review.
Kunder V; Sharma KC; Rizvi Z; Soubelet R; Ducharme M
Cureus; 2023 Aug; 15(8):e43452. PubMed ID: 37711926
[TBL] [Abstract][Full Text] [Related]
6. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
7. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial.
Li L; Chen D; Wang C; Yuan N; Wang Y; He L; Yang Y; Chen L; Liu G; Li X; Ran X
Wound Repair Regen; 2015; 23(4):495-505. PubMed ID: 25847503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: A single-arm clinical trial.
Mohammadi MH; Molavi B; Mohammadi S; Nikbakht M; Mohammadi AM; Mostafaei S; Norooznezhad AH; Ghorbani Abdegah A; Ghavamzadeh A
Transfus Apher Sci; 2017 Apr; 56(2):160-164. PubMed ID: 27839965
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds: A Systematic Review and Meta-analysis.
Qu W; Wang Z; Hunt C; Morrow AS; Urtecho M; Amin M; Shah S; Hasan B; Abd-Rabu R; Ashmore Z; Kubrova E; Prokop LJ; Murad MH
Mayo Clin Proc; 2021 Sep; 96(9):2407-2417. PubMed ID: 34226023
[TBL] [Abstract][Full Text] [Related]
11. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers.
Ahmed M; Reffat SA; Hassan A; Eskander F
Ann Vasc Surg; 2017 Jan; 38():206-211. PubMed ID: 27522981
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: A randomized clinical trial in Tehran, Iran.
Malekpour Alamdari N; Shafiee A; Mirmohseni A; Besharat S
Diabetes Metab Syndr; 2021; 15(2):621-626. PubMed ID: 33740736
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
Driver VR; Hanft J; Fylling CP; Beriou JM;
Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study.
Saad Setta H; Elshahat A; Elsherbiny K; Massoud K; Safe I
Int Wound J; 2011 Jun; 8(3):307-12. PubMed ID: 21470370
[TBL] [Abstract][Full Text] [Related]
15. Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma.
Yotsu RR; Hagiwara S; Okochi H; Tamaki T
J Dermatol; 2015 Mar; 42(3):288-95. PubMed ID: 25615024
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study.
Roth-Albin I; Mai SHC; Ahmed Z; Cheng J; Choong K; Mayer PV
Can J Diabetes; 2017 Feb; 41(1):26-32. PubMed ID: 27634016
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
18. Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report.
Mehrannia M; Vaezi M; Yousefshahi F; Rouhipour N
Can J Diabetes; 2014 Feb; 38(1):5-8. PubMed ID: 24485205
[TBL] [Abstract][Full Text] [Related]
19. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
20. Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study.
Löndahl M; Tarnow L; Karlsmark T; Lundquist R; Nielsen AM; Michelsen M; Nilsson A; Zakrzewski M; Jörgensen B
J Wound Care; 2015 Apr; 24(4):172-4, 176-8. PubMed ID: 25853474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
